These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vasodilators and the use of cyclospasmol in peripheral vascular disease. MAHL MM Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381 [No Abstract] [Full Text] [Related]
8. The melting-point of cyclospasmol and the quantitative determination of small amounts of 3.5.5.-trimethylcyclohexyl phenylglyoxylate in same. REKKER RF; ERNSTING MJ; NAUTA WT Pharm Weekbl; 1956 Jan; 91(1):1-6. PubMed ID: 13310216 [No Abstract] [Full Text] [Related]
9. The treatment of peripheral vascular diseases with cyclospasmol (mandelic acid ester of 3, 5, 5-trimethylcyclohexanol). VAN WIJK TW Angiology; 1953 Apr; 4(2):103-13. PubMed ID: 13040814 [No Abstract] [Full Text] [Related]
11. [Ulcus cruris; a clinical-etiological study with special consideration of postthrombotic and varicose ulcus cruris. With a review of the postthrombotic syndrome]. STURUP H Nord Med; 1951 Aug; 46(33):1251. PubMed ID: 14882597 [No Abstract] [Full Text] [Related]
12. Clinical results with high doses of cyclandelate. HORNSTEIN LS Angiology; 1961 Sep; 12():435-9. PubMed ID: 13715920 [No Abstract] [Full Text] [Related]
13. [ATTEMPTS AT TREATMENT OF LEG ULCERS BY VASODILATATION UNDER STASIS]. WORINGER F; ROTH L Strasb Med; 1963; 14():588-97. PubMed ID: 14134829 [No Abstract] [Full Text] [Related]
14. [Obliteration therapy with devaricene in ulcus cruris]. SEIDEL W Z Arztl Fortbild (Jena); 1953 Apr; 47(8):269-71. PubMed ID: 13078790 [No Abstract] [Full Text] [Related]
15. [Light and dry therapy of ulcus cruris]. ASBECK F Munch Med Wochenschr; 1953 Mar; 95(13):369-72. PubMed ID: 13072383 [No Abstract] [Full Text] [Related]